We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Winmark
WINA
$1.32B
| $3.88M | ﹤0.01% |
16,461
+2,991
| +22% | +$713K |
|
|
MFA
2027
MFA Financial
MFA
$933M
| $3.88M | ﹤0.01% |
393,810
+42,084
| +12% | +$423K |
|
2028
Crescent Energy
CRGY
$3.82B
| $3.86M | ﹤0.01% |
322,143
+168,754
| +110% | +$2.32M |
|
2029
Peapack-Gladstone Financial
PGC
$812M
| $3.86M | ﹤0.01% |
103,615
-13,925
| -12% | -$531K |
|
2030
OraSure Technologies
OSUR
$279M
| $3.85M | ﹤0.01% |
798,295
+340,366
| +74% | +$1.56M |
|
2031
Allegiant Air
ALGT
$2.57B
| $3.83M | ﹤0.01% |
56,310
+6,420
| +13% | +$468K |
|
2032
S&T Bancorp
STBA
$1.79B
| $3.83M | ﹤0.01% |
111,970
-19,521
| -15% | -$684K |
|
2033
ImmunityBio
IBRX
$8.1B
| $3.83M | ﹤0.01% |
248,898
-21,085
| -8% | -$116K |
|
2034
nCino
NCNO
$2.1B
| $3.81M | ﹤0.01% |
144,242
-824
| -0.6% | -$23.2K |
|
|
FARO
2035
DELISTED
Faro Technologies
FARO
| $3.81M | ﹤0.01% |
129,588
-8,403
| -6% | -$250K |
|
|
NGM
2036
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.8M | ﹤0.01% |
757,753
+18,943
| +3% | +$119K |
|
2037
Clean Energy Fuels
CLNE
$346M
| $3.79M | ﹤0.01% |
728,739
-85,410
| -10% | -$525K |
|
2038
Matthews International
MATW
$739M
| $3.78M | ﹤0.01% |
124,277
-13,270
| -10% | -$371K |
|
2039
CareDx
CDNA
$2.42B
| $3.75M | ﹤0.01% |
329,071
-37,853
| -10% | -$561K |
|
|
HCCI
2040
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $3.75M | ﹤0.01% |
115,361
+3,516
| +3% | +$106K |
|
2041
Byline Bancorp
BY
$1.76B
| $3.73M | ﹤0.01% |
162,266
+26,139
| +19% | +$586K |
|
2042
Ubiquiti
UI
$34.3B
| $3.72M | ﹤0.01% |
13,585
-3,480
| -20% | -$1.04M |
|
2043
Marten Transport
MRTN
$1.22B
| $3.71M | ﹤0.01% |
187,694
-37,097
| -17% | -$740K |
|
2044
Brookdale Senior Living
BKD
$3.4B
| $3.71M | ﹤0.01% |
1,358,434
+658,553
| +94% | +$2.46M |
|
|
CTO
2045
CTO Realty Growth
CTO
$815M
| $3.71M | ﹤0.01% |
198,493
+125,967
| +174% | +$2.42M |
|
|
FSR
2046
DELISTED
Fisker Inc.
FSR
| $3.7M | ﹤0.01% |
508,489
+51,755
| +11% | +$385K |
|
2047
Ginkgo Bioworks
DNA
$521M
| $3.69M | ﹤0.01% |
54,588
-16,297
| -23% | -$1.5M |
|
2048
Pediatrix Medical
MD
$2.2B
| $3.69M | ﹤0.01% |
248,310
-50,416
| -17% | -$823K |
|
2049
Ooma
OOMA
$604M
| $3.69M | ﹤0.01% |
270,632
+18,801
| +7% | +$278K |
|
2050
Syndax Pharmaceuticals
SNDX
$1.82B
| $3.69M | ﹤0.01% |
144,862
-21,015
| -13% | -$490K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.